Addict Biol. 2019 Jan 8. doi: 10.1111/adb.12706.
[Epub ahead of print]
Roura-Martínez D1, Ucha M1, Orihuel J1, Ballesteros-Yáñez I2, Castillo CA3, Marcos A1, Ambrosio E1, Higuera-Matas A1.
Abstract
Relapse into drug use is a major problem faced by recovering addicts. In humans, an intensification of the desire for the drug induced by environmental cues-incubation of drug craving-has been observed. In rodents, this phenomenon has been modeled by studying drug seeking under extinction after different times of drug withdrawal (or using a natural reinforcer). Although much progress has been made, an integrated approach simultaneously studying different drug classes and natural reward and examining different brain regions is lacking. Lewis rats were used to study the effects of cocaine, heroin, and sucrose seeking incubation on six key brain regions: the nucleus accumbens shell/core, central/basolateral amygdala, and dorsomedial/ventromedial prefrontal cortex. We analyzed PSD95 and gephyrin protein levels, gene expression of glutamatergic, GABAergic and endocannabinoid elements, and amino acid transmitter levels. The relationships between the areas studied were examined by Structural Equation Modelling. Pathways from medial prefrontal cortex and basolateral complex of the amygdala to central nucleus of the amygdala, but not to the nucleus accumbens, were identified as common elements involved in the incubation phenomenon for different substances. These results suggest a key role for the central nucleus of amygdala and its cortical and amygdalar afferences in the incubation phenomenon, and we suggest that by virtue of its regulatory effects on glutamatergic and GABAergic dynamics within amygdalar circuits, the endocannabinoid system might be a potential target to develop medications that are effective in the context of relapse.
© 2019 Society for the Study of Addiction.
KEYWORDS:
central nucleus of the amygdala; drugs of abuse; endocannabinoid system; incubation of seeking; natural rewards; nucleus accumbens
- PMID: 30623520
- DOI: 10.1111/adb.12706
-
Grant support
Grant support
- JUST/2013/DPIP/AG/4823-EU MADNESS/European Union/
- S-2011 / BMD-2308/General Directorate of Research of the Community of Madrid/
- PNSD2012I057/Spanish Ministry of Health, Social Services and Equality/
- RTA-RD12/028/0020/Spanish Ministry of Health, Social Services and Equality/
- Plan de Promoción de la Investigación/UNED/
- S-2011/BMD-2308/Genera Directorate of Research of the Community of Madrid/
- 2012I057/Institute of Health Carlos III and Plan Nacional Sobre Drogas/
- PSI2016-80541-P/Spanish Ministry of Economy and Competitiveness/
- SAF2013-47520-P/Spanish Ministry of Economy and Competitiveness/